Showing Results for
- Academic Journals (29)
Search Results
- 29
Academic Journals
- 29
- Search Terms:
- 1From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedDrug-induced adverse effects are an important area of intervention for pharmacists. The emergence of postmarketing safety data for rosiglitazone, propoxyphene, and rofecoxib stresses the importance of drug monitoring...
- 2From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedDENVER, CO JUNE 14, 2011 The new professional policies approved by the ASHP House of Delegates at its June 2011 session are listed below. Policies proposed by councils or other ASHP bodies are first considered by the...
- 3From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedAstate-funded information technology (IT) pilot project at Inova Alexandria Hospital in Virginia is speeding the process of medication reconciliation in the emergency department and helping clinicians make decisions...
- 4From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedPurpose. The stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride (PVC) and polyolefin bags under varying conditions was evaluated. Methods. Triplicate solutions of midazolam...
- 5From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedFentanyl nasal spray (Lazanda, Archimedes Pharma): The product is indicated for the management of breakthrough pain in cancer patients, age 18 years or older, who are already receiving and are tolerant to opioid therapy...
- 6From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedOn June 14, 2011, ASHP presented Marie A. Chisholm-Burns, Pharm.D., M.P.H., FCCP, FASHP, with the Society's Award of Excellence. The award, established in 2005 as the successor to the ASHP Certificate of...
- 7From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedPurpose. The pharmacology, pharmacokinetics, clinical efficacy, tolerability, dosage and administration, and place in therapy of dabigatran etexilate are reviewed. Summary. Dabigatran is a reversible direct thrombin...
- 8From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedAnew oral option, rivaroxaban, has become available for preventing deep vein thrombosis and subsequent pulmonary embolism in patients who have undergone knee or hip replacement surgery. FDA on July 1 approved the...
- 9From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedAs described in this issue of AJHP (see page 1506), dabigatran etexilate is the first oral direct thrombin inhibitor and the first oral anticoagulant since warfarin to become available in the United States. In contrast...
- 10From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedStanley S. Kent President and Chair of the Board Diane B. Ginsburg Immediate Past-President Philip J. Schneider Treasurer Gerald E. Meyer Chair, House of Delegates Larry Clark Lisa M. Gersema...
- 11From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedGood afternoon, and welcome to Denver. I am truly honored to report to you what has been happening over the last year. You might remember that a year ago in my inaugural address I promised to "get it started." I...
- 12From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedVirginia Governor Bob McDonnell in June announced that the University of Virginia Medical Center in Charlottesville had won the 2011 Innovation Award in public service. He credited several medical center employees for...
- 13From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedThe American College of Clinical Pharmacy (ACCP) and the American Society of Health System Pharmacists (ASHP) each have established a vision that, by 2020, postgraduate year 1 (PGY1) residency training should be...
- 14From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedFDA's recent abandonment of once-standard hemoglobin targets for erythropoeisis-stimulating agents (ESAs) in patients with chronic kidney disease is prompting changes in patient care. Agency officials on June 24...
- 15From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedPurpose. The stability of diluted adenosine solutions in polyvinyl chloride infusion bags was studied. Methods. Adenosine 50-, 100-, and 220[micro]g/mL solutions were prepared in 50-mL polyvinyl chloride (PVC)...
- 16From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedLevothyroxine solution for injection (APP Pharmaceuticals): The product is indicated for the treatment of myxedema coma....
- 17From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedPurpose. The pharmacodynamics and therapeutic effects of extended-infusion (EI) piperacillin-tazobactam therapy are reviewed, with an emphasis on growing evidence of its advantages over traditional infusion schemes....
- 18From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedJohnson & Johnson in June renamed three of its pharmaceutical companies. Janssen Therapeutics is the new name for Tibotec Therapeutics. Janssen Pharmaceuticals Inc. is the new name for Ortho-McNeil-Janssen...
- 19From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedI want to start today by saying that I have enjoyed being your executive for the past 16 years. It has been a privilege and an honor to serve as this House's secretary and, more broadly, as the executive vice president...
- 20From: American Journal of Health-System Pharmacy. (Vol. 68, Issue 16) Peer-ReviewedPurpose. A case of persistent multidrug-resistant (MDR) Acinetobacter baumannii ventriculitis successfully treated with a prolonged and novel combination of antimicrobials is reported. Summary. A 38-year-old, 84-kg...